School-based Treatment of Anxiety Research Study (STARS) (STARS)
Modular CBT for Reducing Anxiety and Improving Educational Outcomes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Farmington, Connecticut, United States, 06030
- University of Connecticut Health Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- between the ages of 6-18 inclusively
- meet DSM-IV criteria for a primary anxiety disorder
Exclusion Criteria:
- presence of a medical or psychiatric condition contraindicating study treatment (e.g., suicidal intent)
- need more immediate or alternative treatment
- receiving psychosocial treatment for anxiety
- victim of previously undisclosed child abuse and require ongoing Department of Children and Families (DCF) supervision
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: CBT
Cognitive behavioral therapy
|
Other Names:
|
|
Active Comparator: UC
Usual care
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impressions Improvement Scale
Time Frame: 12 weeks post-treatment
|
Improvement in Clinical Anxiety Diagnosis
|
12 weeks post-treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
School Records
Time Frame: 12 weeks post-treatment
|
Academic functioning
|
12 weeks post-treatment
|
|
Teacher Report Form
Time Frame: 12 weeks post-treatment
|
classroom behavior and performance
|
12 weeks post-treatment
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screen for Child Anxiety Related Emotional Disorders
Time Frame: 12 weeks post-treatment
|
Additional measures of symptoms, mediators, and moderators
|
12 weeks post-treatment
|
|
Children's Automatic Thoughts Scale
Time Frame: 12 weeks post-treatment
|
Cognitive distortions related to anxiety
|
12 weeks post-treatment
|
|
Woodcock-Johnson Tests of Achievement
Time Frame: 12 weeks post-treatment
|
Academic achievement and working memory
|
12 weeks post-treatment
|
|
Children's Global Assessment Scale
Time Frame: 12 weeks post-treatment
|
Global Functioning
|
12 weeks post-treatment
|
|
Brief Symptom Inventory
Time Frame: 12 weeks post-treatment
|
Parental psychopathology
|
12 weeks post-treatment
|
|
The TCU Organizational Readiness to Change
Time Frame: 12 weeks post-treatment
|
Clinician's perceptions of workplace attributes
|
12 weeks post-treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Golda S Ginsburg, Ph.D., University of Connecticut
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NA00075767
- R324A120405 (Other Grant/Funding Number: Institute of Educational Sciences (IES))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.